As a successful strategy for new drug discovery, next-generation probiotics (NGPs) have shown its potential in various disease treatment, especially for malignant tumors. Creative Biolabs provides a panel of Enterococcus faecium (E. faecium)-based services to support NGP development. Our multidisciplinary team will provide flexible solutions for E. faecium probiotic design, evaluation, and pre-clinical testing. To date, we have won a good reputation among our worldwide customers for accomplishing numerous challenging projects in this field. Learn more: enterococcus faecium as next generation probiotics